PHDS HEALTHCARE RESEARCH Co., Ltd.
The CEO was invited to speak at the "3rd China Health Industry Conference and Great Health Industry Brand Ceremony".
Release time:
2021-06-11
In June 2021, the CEO of Boshi Zhixing was invited as a guest to attend the "3rd China Health Industry Conference and the Grand Health Industry Brand Ceremony," with the theme "Striving for a New Journey in the 14th Five-Year Plan, Building a New Pattern for the Development of the Health Industry."
In June 2021, the CEO of Boshi Zhixing was invited as a guest to attend the "3rd China Health Industry Conference and the Grand Health Industry Brand Ceremony." The conference was themed "Striving for a New Journey in the 14th Five-Year Plan, Building a New Pattern for the Development of the Health Industry." Our company's CEO delivered a speech at the opening ceremony of the conference:"Shifting from a disease-centered approach to a people-centered health approach". As an international CRO company,we will extend from pharmaceutical research and development technical services to the development of a health ecosystem.We will move from a single pharmaceutical technology service to independently developed patented health products, actively engaging in the grand cause of industrial planning, product development, ecological utilization, and rural revitalization, contributing our own strength to the health of 1.4 billion Chinese people, which received enthusiastic responses from the attendees.
To deeply interpret the theme's meaning and grasp the development trends of the health industry during the 14th Five-Year Plan, the conference invited relevant academicians, experts, scholars, industry representatives, and other figures from all walks of the health industry to attend this conference. During the meeting, relevant leaders and entrepreneurs discussed the new opportunities and future of China's health industry during the 14th Five-Year Plan, collectively exchanging ideas on topics such as building a new pattern for the development of the health industry in the first year of the 14th Five-Year Plan, promoting Healthy China initiatives, and how the health industry can support rural revitalization. The conference also held numerous activities, including the China Brand Ceremony, thematic reports, parallel forums, dialogues, special promotions, brand exhibitions, and VIP networking.
The secretary-general of the conference organizing committee introduced: "After the COVID-19 pandemic, the health industry has faced tremendous challenges, such as in medical and health services, traditional Chinese medicine, women's reproductive health, smart healthcare, health management, and modern agriculture, yet the health industry has welcomed a new period of industrial development opportunities. This year, at the beginning of the 14th Five-Year Plan and the centenary of the founding of the Communist Party, the 3rd China Health Industry Conference injects new vitality while providing participating enterprises with a collision of new thinking and wisdom in the health industry. It also helps achieve a positive coordination between health and economic and social development."
Keyword:
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22
What if you have more needs?
Leave your demand information online and we will reply to you in time!
Contact Information
Customer service hotline:
E-mail:customer@cnphds.com
Address: Building A, Ocean Express,66 Xia Guang Li, Dong San Huan North Road,Chaoyang district, Beijing, China
Mobile
Public Number
京公网安备11010502056452号